Standard Chartered has expanded its Global Chief Investment Office team with the appointments of Sundeep Gantori as Chief Investment Officer, Equities, and Jonathan Liang as Chief Investment Officer, ...
Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback